Literature DB >> 17219965

Expression of survivin, CDK4, Ki-67 and clinical significance in pediatric acute leukemia.

Liuqing Zhang1, Jing Liu, Hanhua Lin, Qun Hu, Aiguo Liu, Ying Hu.   

Abstract

The expression of Survivin, CDK4 and Ki-67 and the clinical significance in pediatric acute leukemia (AL) were investigated. The expression of Survivin, CDK4 and Ki-67 proteins was detected by using immunohistochemical assay in 37 children with AL and 10 children with normal bone marrow as controls. The positive expression rate of Survivin, CDK4 and Ki-67 was 45.9 %, 56.8 %, and 40.5 % respectively in 37 AL children, which was significantly higher than in control group accordingly (P<0.05). The expression of Survivin was positively correlated with CDK4 (P=0.007) and Ki-67 (P=0.008). In conclusion, all Survivin, CDK4 and Ki-67 proteins are over-expressed in pediatric AL and involved in the modulation of apoptosis and proliferation in pediatric AL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17219965     DOI: 10.1007/s11596-006-0517-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Survivin promotes cell proliferation in human hepatocellular carcinoma.

Authors:  T Ito; K Shiraki; K Sugimoto; T Yamanaka; K Fujikawa; M Ito; K Takase; M Moriyama; H Kawano; M Hayashida; T Nakano; A Suzuki
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

Review 2.  The inhibitor of apoptosis protein family and its antagonists in acute leukemias.

Authors:  A Wrzesień-Kuś; P Smolewski; A Sobczak-Pluta; A Wierzbowska; T Robak
Journal:  Apoptosis       Date:  2004-11       Impact factor: 4.677

Review 3.  Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice.

Authors:  Aaron D Schimmer
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

4.  Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

Authors:  H Kawasaki; D C Altieri; C D Lu; M Toyoda; T Tenjo; N Tanigawa
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  Aberrant regulation of survivin by the RB/E2F family of proteins.

Authors:  Yuying Jiang; Harold I Saavedra; Michael P Holloway; Gustavo Leone; Rachel A Altura
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

6.  A cell cycle regulator potentially involved in genesis of many tumor types.

Authors:  A Kamb; N A Gruis; J Weaver-Feldhaus; Q Liu; K Harshman; S V Tavtigian; E Stockert; R S Day; B E Johnson; M H Skolnick
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

7.  Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.

Authors:  G Reifenberger; J Reifenberger; K Ichimura; P S Meltzer; V P Collins
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

8.  Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.

Authors:  Mizuki Ikehara; Fumihiro Oshita; Yoichi Kameda; Hiroyuki Ito; Naoki Ohgane; Rie Suzuki; Haruhiro Saito; Kouzo Yamada; Kazumasa Noda; Aki Mitsuda
Journal:  Oncol Rep       Date:  2002 Jul-Aug       Impact factor: 3.906

  8 in total
  1 in total

1.  Rational design of the survivin/CDK4 complex by combining protein-protein docking and molecular dynamics simulations.

Authors:  Jana Selent; Agnieszka A Kaczor; Ramon Guixà-González; Pau Carrió; Manuel Pastor; Cristian Obiol-Pardo
Journal:  J Mol Model       Date:  2012-12-21       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.